Tue, June 25, 2024
Mon, June 24, 2024
Fri, June 21, 2024
Thu, June 20, 2024
Wed, June 19, 2024
Tue, June 18, 2024

Matthew Harrison Reiterated (SRPT) at Buy and Held Target at $165 on, Jun 21st, 2024


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. buy-and-held-target-at-165-on-jun-21st-2024.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Matthew Harrison of Morgan Stanley, Reiterated "Sarepta Therapeutics, Inc." (SRPT) at Buy and Held Target at $165 on, Jun 21st, 2024.

Matthew has made no other calls on SRPT in the last 4 months.



There are 6 other peers that have a rating on SRPT. Out of the 6 peers that are also analyzing SRPT, 0 agree with Matthew's Rating of Hold.



These are the ratings of the 6 analyists that currently disagree with Matthew


  • Kostas Biliouris of "BMO Capital" Maintained at Buy and Held Target at $170 on, Tuesday, June 18th, 2024
  • Uy Ear of "Mizuho" Maintained at Strong Buy with Increased Target to $179 on, Friday, May 17th, 2024
  • Hartaj Singh of "Oppenheimer" Upgraded from Hold to Buy and Held Target at $180 on, Tuesday, May 14th, 2024
  • Anupam Rama of "JP Morgan" Maintained at Buy with Decreased Target to $175 on, Friday, May 3rd, 2024
  • Colin Bristow of "UBS" Maintained at Strong Buy with Increased Target to $167 on, Friday, March 1st, 2024
  • David Hoang of "Citigroup" Maintained at Strong Buy with Increased Target to $172 on, Thursday, February 29th, 2024

Publication Contributing Sources